REXAHN PHARMACEUTICALS INC's ticker is REXN and the CUSIP is 761640309. A total of 17 filers reported holding REXAHN PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Royal Fund Management, LLC | 4 | $0 | 0.00% |
| American Portfolios Advisors | 8 | $15 | 0.00% |
| Renaissance Technologies | 148,333 | $283,000 | 0.00% |
| ROYAL BANK OF CANADA | 20 | $0 | 0.00% |
| VANGUARD GROUP INC | 55,584 | $106,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 49 | $0 | 0.00% |
| TCI Wealth Advisors, Inc. | 8 | $0 | 0.00% |
| UBS Group AG | 6,340 | $12,000 | 0.00% |
| NEXT Financial Group, Inc | 166 | $0 | 0.00% |
| Advisor Group, Inc. | 23 | $0 | 0.00% |